Allogeneic Hematopoetic Stem Cell Transplant for Patients With Refractory T Cell Lymphomas

The authors compared transplant outcomes between refractory-T cell non-Hodgkin lymphomas (T-NHL) and Chemosensitive-T-NHL (CS-T-NHL). They reviewed the records of 26 refractory-NHL and 29 CS-T-NHL consecutive patients who underwent allogeneic stem cell transplantation.